New Launches And Regulatory Approvals For Orthopedic Devices To Solve Existing Issues

Orthopedic surgeries need advanced and innovative devices to ensure that the treatments are carried out effectively and patients do no suffer from complications after the procedures. Many traditional devices pose uncertainty even after the procedure and implantation. The movable devices led to increased pain following the months of the procedure in patients. Moreover, the compatibility issues presented many challenges for surgeons. Manufacturers of orthopedic devices took many issues into consideration and developed devices that would solve those issues and improve the quality of treatment. Consequently, they will make a huge difference in quality of the lives of patients. Many devices have been launched; while, many devices availed the approval from regulatory bodies. The launch of innovative orthopedic devices will continue in the coming years.

New device to treat fractures in children

Market players are launching new products to surge their offerings and solve the existing issues. OrthoPediatrics Corp. launched a new PediFlex Advanced Interlock Clamp System. This launch presents a significant advancement in the existing surgical system. The newly-launched system offers surgeons with necessary options while utilizing elastic and stable intramedullary nails for treatment of fractures in children. These clamps are available in stainless steel and titanium options and provide compatibility with sizes ranging from 1.5 mm to 4.5 mm. The company highlighted that it launched the system for solving the issues related to implants and unwanted nail stability & migration. It also highlighted that this launch will disrupt the traditional flexible nails used in the pediatric orthopedic fractures with the fixed nailing in children. The innovative solution with also improve the lives of children across the world. The launch of such innovative products will carry on in the next few years as orthopedic surgeons look for solutions in various treatment procedures.

FDA Approval for New Orthopedic Device

As some innovative products have been launched, some products gained the approval from the regulatory bodies. The Orthopaedic Implant Company (OIC) based in Nevada, availed the approval of the U.S. Food and Drug Administration (FDA) for its dorsal spanning plate. The company made the product commercially available in the U.S. after the approval. This product is nothing but the first high-quality dorsal spanning plate, according to the company. This plate will be added to the trauma implant portfolio for improving the effect of DRPx wrist fracture plating system.

Commenting on the approval and the commercial launch of the dorsal spanning plate, Itai Nemovicher, the President and Chief Executive Officer of OIC, highlighted that the addition of the dorsal spanning plate to the DRPx system will offer surgeons and facilities an opportunity to substantially raise the value of a high-volume procedure, streamline the operations, and avail the clinical results the similar results they availed with the expensive implant systems. So, the plate will offer cost-cutting benefits and make the treatment affordable for patients. The endeavor to launch innovative products that offer cost-effectiveness and high functionality will continue and the next few years will witness the launch of more products than before.

Related Post